John Stanford
speaker
1,479 appearances
11 recordings
1 series
first heard May 2026
last heard 13 Aug
John Stanford’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 11 in all, peaking in Jul 2026 with 4.
Appearances
And I think you did a great job of giving some tangible examples of when a company, when it's ready to leave UNC, it was, okay, maybe we can get from the Petri dish to mice and
But manufacturing enough and going into primates, that's when let's build a company, let's use SBIR.
When do you know you're unique in the sense that you've got your own personal data set?
When did you know that you were at the other end of the spectrum, that it was time to hand something off
to a Pfizer, to a Baxter, to others.
What are some of the telltale signs that early stage entrepreneur and company
is ready to now hand it off.
What do you look for?
I mean, again, you're so great about pointing to sort of the tangible moments in time, manufacturing and clinical trials at scale were two telltale signs that it needed to be handed off.
I guess, again, you come with a perspective of having done this so many times.
Is this the right way, this relay race, this you do this, you do this?
I sometimes hear from members of Congress, why can't our small biotechs go on to –
do it themselves.
I don't like this relay race.
I don't like this handoff.
I find it to be very efficient, but I'm curious, you've been through it.
Is the way we do these things, the innovation comes out, we build up these small to mid-sized biotechs, and then we hand it off.
And the manufacturers who really do navigate manufacturing and global clinical trials and leverage their capital bases,
Is this the right recipe or are there some tweaks you'd make to it?
Don't want you on my call sheet when I've disappointed you.
Showing 261–280 of 1,479 · page 14 of 74
← Previous
Next →